Study of Recombinant Human Coagulation Factor VIIa for Injection (FⅦa) in Patients With Hemophilia.

Clinical trial NCT04768699 · UNKNOWN

Trial details

NCT number: NCT04768699
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Hemophilia A With Inhibitor Hemophilia B With Inhibitor

Start date: 2020-12-01
Primary completion: 2021-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.